Saleh El-Husayni

Saleh El-husayni is a seasoned professional in clinical biomarker operations and translational development, currently serving as the Clinical Biomarker Operations Lead at Takeda Oncology. With a robust background that includes roles as an Operations Scientist at Sana Biotechnology, Project Manager at Editas Medicine, and Senior Clinical Research Associate at Sarepta Therapeutics, Saleh has extensive experience in overseeing bioanalytical assay development, regulatory submissions, and cross-department collaborations. Previous contributions include leading clinical trial analyses, managing vendor contracts, and facilitating training for clinical sites, all while ensuring compliance with GCLP guidelines. Saleh's academic foundation is a Bachelor of Science in Biochemistry from Northeastern University.